Is UNII-Q13WX941EF Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use UNII-Q13WX941EF? Is UNII-Q13WX941EF safe for nursing mother and child? Does UNII-Q13WX941EF extracts into breast milk? Does UNII-Q13WX941EF has any long term or short term side effects on infants? Can UNII-Q13WX941EF influence milk supply or can UNII-Q13WX941EF decrease milk supply in lactating mothers?
UNII-Q13WX941EF lactation summary
- DrLact safety Score for UNII-Q13WX941EF is 3 out of 8 which is considered Low Risk as per our analyses.
- A safety Score of 3 indicates that usage of UNII-Q13WX941EF may cause some minor side effects in breastfed baby.
- Our study of different scientific research indicates that UNII-Q13WX941EF may cause moderate to no side effects in lactating mother.
- Most of scientific studies and research papers declaring usage of UNII-Q13WX941EF low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- While using UNII-Q13WX941EF We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About UNII-Q13WX941EF usage in lactation
It is a not sedative anti-histaminic (second generation) drug without an anti-muscarinic activity.
Answer by DrLact: About UNII-Q13WX941EF usage in lactation
Because absorption from the eye is limited, UNII-Q13WX941EF would not be expected to cause any adverse effects in breastfed infants. To substantially diminish the amount of drug that reaches the breastmilk after using eye drops, place pressure over the tear duct by the corner of the eye for 1 minute or more, then remove the excess solution with an absorbent tissue.
UNII-Q13WX941EF Side Effects in Breastfeeding
There are no reports of infants breastfed during maternal therapy with UNII-Q13WX941EF. In one telephone follow-up study, mothers reported irritability and colicky symptoms in 10% of infants exposed to various antihistamines and drowsiness was reported in 1.6% of infants. None of the reactions required medical attention.[1]
UNII-Q13WX941EF Possible Effects in Breastfeeding
Antihistamines in relatively high doses given by injection can decrease basal serum prolactin in nonlactating women and in early postpartum women.[2][3] However, suckling-induced prolactin secretion is not affected by antihistamine pretreatment of postpartum mothers.[2] The prolactin level in a mother with established lactation may not affect her ability to breastfeed. Low ophthalmic doses of UNII-Q13WX941EF are unlikely to have the same effect on serum prolactin.
Alternate Drugs
Carbinoxamine(Low Risk)
Brompheniramine(Low Risk)
Pyrilamine(Low Risk)
Azelastine(Low Risk)
Loratadine(Safe)
Acrivastine(Low Risk)
Hydroxyzine(Safe)
Fexofenadine(Safe)
Doxylamine(Unsafe)
Diphenhydramine(Low Risk)
Cyclizine(Low Risk)
Dimenhydrinate(Low Risk)
Dexchlorpheniramine(Low Risk)
Levocetirizine(Low Risk)
Ketotifen(Low Risk)
Desloratadine(Safe)
Clemastine(Low Risk)
Meclizine(Low Risk)
Chlorpheniramine(Low Risk)
Epinastine(Low Risk)
Cetirizine(Safe)
Triprolidine(Safe)